News
An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions ...
Strong Q1 sales of $137.3M showcase Madrigal Pharmaceuticals, Inc.'s Rezdiffra's growth in non-cirrhotic NASH. Click for my ...
A recent dual-cohort study has found that Lupus Low Disease Activity State (LLDAS) is an attainable and effective treatment ...
Panelists discuss how quality of life (QOL) and treatment convenience should be balanced with maximal depth of response through personalized therapy approaches, emphasizing the importance of ...
We started the company 17 years ago with the goal of helping cancer patients live longer and longer until they eventually outlive their disease. We can transform cancer into something that's more of a ...
Data shared by Schneider showed that 45% of those originally assigned to the Eylea HD groups had completed dosing intervals of 20 weeks or more. At the end of the 156-week trial, 28% had an assigned ...
The “princess treatment” TikTok dating trend has been making the rounds for the past year or so. It’s mostly been pretty harmless, consisting of women showing off the romantic things their partners do ...
New findings reveal Syfovre may protect central vision in macular degeneration patients, delaying vision loss and enhancing treatment strategies.
As July concludes, new treatments offer advances across kidney and bladder cancer, with breakthroughs in personalized vaccines and non-surgical therapies.
Bristol Myers Squibb said on Friday its blockbuster drug Reblozyl in combination with another therapy failed to meet the main ...
The health department has R622-million extra to prop up South Africa’s HIV treatment programme in the wake of foreign aid cuts. But it’s only about a fifth of the total gap. We look at how data can ...
Q-TWiST may help patients with advanced kidney cancer and their doctors weigh treatment options by focusing on quality of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results